Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 11, 2025Bulletin of Siberian MedicineOpen Access

Associations of visceral adipose tissue adipokines with metabolic disorders in abdominal obesity

View Full Paper
Ask AI
Bookmark
Share

Authors

OTO. V. TuzovskaiaYPYа. V. PolonskayaEGE. V. Garbuzova

Discussion

Loading...

Member takes

Overview

Observational analysis identified associations between adiponectin and metabolic disorders in adults, suggesting adipokines play a vital role.

Key Points

  • Adiponectin levels inversely correlate with metabolic parameters in men aged 45–65 years, highlighting its significance.
  • Key evidence shows a weak negative relationship between adiponectin and waist circumference, with implications for obesity management.
  • The method involved measuring blood adipokines and correlating them with metabolic disorders across 101 individuals.
  • Findings emphasize the possible role of visceral adipose tissue adipokines in assessing cardiometabolic health.

Cite This Study

Tuzovskaia et al. (2025) studied this question.

synapsesocial.com/papers/68a35efb0a429f79733287b2https://doi.org/10.20538/1682-0363-2025-2-116-123
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Associations of proinflammatory cytokines of visceral adipose tissue with metabolic disorders in abdominal obesity2025
  2. 2Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia2004 · 151 citations
  3. 3Cross-Sectional Associations Bet ween Abdominal and Thoracic Adipose Tissue Compartments and Adiponectin and Resistin in the Framingham Heart Study2009 · 80 citations
  4. 4Cross-sectional associations of adipokines and abdominal fat distribution with aging in men2020 · 8 citations
  5. 5The relation between body fat distribution, plasma concentrations of adipokines and the metabolic syndrome in patients with clinically manifest vascular disease2018 · 43 citations